A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sorafenib Impurity 5 | CAS 88330-63-6 - Request Quote

Picture of Sorafenib Impurity 5

Sorafenib Impurity 5

SZ CAT No:SZ-S012039
CAS No
88330-63-6
Mol.F.
C8H3ClF3NO
Mol.Wt.
221.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sorafenib Impurity 5 is chemically 2-Chloro-1-isocyanato-3-(trifluoromethyl)benzene. Sorafenib Impurity 5 is supplied with detailed characterization data compliant with regulatory guideline. Sorafenib Impurity 5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sorafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 88330-63-6

Purchase 88330-63-6

Order 88330-63-6

Enquire 88330-63-6

price of 88330-63-6

88330-63-6 Supplier

88330-63-6 Manufacturer

88330-63-6 Exporter

buy high quality Sorafenib Impurity 5

Purchase Sorafenib Impurity 5

Sorafenib Impurity 5 suppliers

Sorafenib Impurity 5 manufacturers

Sorafenib Impurity 5 price

Order Sorafenib Impurity 5

Enquire Sorafenib Impurity 5

Sorafenib Impurity 5 cost

Sorafenib Impurity 5 Supplier

Sorafenib Impurity 5 Distributor

Sorafenib Impurity 5 for Method Validation

Sorafenib Reference Standard

Sorafenib Impurity 5 for ANDA Filing

Sorafenib Impurity 5 for Forced Degradation Studies

Sorafenib Impurity 5 Identification Standards

Sorafenib Impurity 5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,